CardieX Limited (ASX:CDX)

Market Cap	20.90M
Revenue (ttm)	5.72M
Net Income (ttm)	-14.55M
Shares Out	550.08M
EPS (ttm)	-0.05
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	903,951
Average Volume	307,333
Open	0.0380
Previous Close	0.0410
Day's Range	0.0370 - 0.0380
52-Week Range	0.0370 - 0.1750
Beta	1.11
RSI	43.08
Earnings Date	Aug 29, 2025

About CardieX

CardieX Limited engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biometric technology that captures central hemodynamics and arterial stiffness for noninvasive measurement of vascular biomarkers including central aortic pressures and arterial stiffness indices. The company also provides medical devices and vascular biomarkers for hypertension, cardiovascular disease, and other vascular health disorders; an...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1994
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CDX

Financial Performance

In 2024, CardieX's revenue was 12.81 million, an increase of 125.14% compared to the previous year's 5.69 million. Losses were -6.77 million, -64.18% less than in 2023.